title: Kidney cancer: VEGFR-TKI after anti-PD-1 therapy is safe.
authors.forename: Louise
authors.initials: L
authors.lastname: Stone
mesh_terms: D000970:Antineoplastic Agents; D002292:Carcinoma, Renal Cell; D006801:Humans; D007680:Kidney Neoplasms; D061026:Programmed Cell Death 1 Receptor; D047428:Protein Kinase Inhibitors
chemical_list: D000970:Antineoplastic Agents; D061026:Programmed Cell Death 1 Receptor; D047428:Protein Kinase Inhibitors